Announced
Completed
Financials
Tags
Single Bidder
Acquisition
Private
Completed
biopharmaceuticals
Majority
Pharmaceuticals
United States
Friendly
Synopsis
JCR Pharmaceuticals, a specialty pharma company engaged in the research, development, manufacturing and marketing of biopharmaceuticals and regenerative medicine, completed the acquisition of ArmaGen, a biopharmaceutical company. Financial terms were not disclosed. "JCR Pharmaceuticals is a very committed player in the field. Together with its solid in-house manufacturing capabilities it is a unique opportunity to leapfrog its innovative developments for the benefit of patients with desperate unmet medical need. The acquisition of ArmaGen is a synergy in its true sense and can catalyze the global market penetration of JCR's LSD portfolio," Mathias Schmidt, ArmaGen President and CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.